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Conditional Deletion of Kit in Melanocytes:
White Spotting Phenotype Is Cell Autonomous
Hitomi Aoki1, Hiroyuki Tomita2, Akira Hara2 and Takahiro Kunisada1
It is well established that cell-intrinsic signaling through the receptor tyrosine kinase KIT is critical for the
development of neural crest–derived melanocytes. Nevertheless, it is not entirely clear whether Kit acts
exclusively in a melanocyte-autonomous manner or in addition indirectly through other cell types. To address
this question in vivo, we generated a targeted allele of Kit that allowed for CRE recombinase-mediated deletion of
the transmembrane domain of KIT. Mice carrying one copy of the targeted allele and expressing CRE under the
melanoblast/melanocyte-speciﬁc tyrosinase promoter exhibited a white spotting phenotype that was even more
extensive compared with that found in mice heterozygous for a Kit-null allele. This phenotype is unlikely the
result of sequestration of KIT ligand by neighboring cells or by potentially secreted forms of KIT because the
spotting phenotype could not be rescued by overexpression of KITL. Likewise, overexpression of endothelin-3 or
hepatocyte growth factor was unable to rescue melanocytes in these mice. Although the severity of the observed
phenotype remains to be explained, the ﬁndings indicate that melanocyte-selective impairment of Kit is sufﬁcient
to interfere with normal melanocyte development.
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INTRODUCTION
Melanocytes develop from pluripotent neural crest cells and
their immature precursors, called melanoblasts, migrate to
various destinations, such as the dermis and the epidermis of
the skin, the inner ear, and the choroid of the eye (for reviews,
see Hall, 1999; Le Douarin and Kalcheim, 2009; Dupin and
Le Dourain, 2014; Kunisada et al., 2014; Motoihashi and
Kunisada, 2015). The tyrosine kinase receptor Kit is expressed
in the melanocyte cell lineage and its ligand, Kitl, is secreted
by environmental cells to transduce the indispensable
signaling through KIT receptor. From ﬁsh to man, signaling
through the tyrosine receptor kinase KIT is critical for the
development of neural crest–derived melanocytes (for
reviews, see Hall, 1999; Le Douarin and Kalcheim, 2009;
Hearing, 2011). In mice, for instance, a plethora of Kit
mutations can lead to white spotting in heterozygotes and the
absence of coat pigmentation in homozygotes (Silvers, 1979;
Geissler et al., 1988; Cable et al., 1995; Wehrle-Haller and
Weston, 1995; Tosaki et al, 2006). Complete absence of KIT
signaling in Kit-null-mutant homozygotes, however, is usually
associated with perinatal lethality because Kit is not only
required in cells of the melanocyte lineage but also in a
number of other cell types such as hematopoietic cells (Galli
et al., 1992; O’Reilly-Pol and Johnson, 2012). Despite the fact
that earlier transplantation and chimera experiments as well
as in vitro tests have highlighted a cell-autonomous action
of Kit in melanocytes, a cell non-autonomous effect brought
about by impairments in other cells that normally provide
proper support for melanocyte migration, growth, and
differentiation (Orr-Urtreger et al., 1990; Motro et al., 1991)
is still conceivable.
To address the question of whether Kit acts exclusively
in a melanocyte-autonomous manner, we here prepared a
line of conditional knock-out mice in which reduction
of KIT signaling is essentially restricted to the melanocyte
lineage. We ﬁnd that functional impairment of Kit in melano-
cytes alone is sufﬁcient to induce a severe white spotting
phenotype. A possible cell non-autonomous effect from other
Kit-dependent cell types was also suggested not to be likely as
transgenic overexpression of the speciﬁc ligand for KIT, KITL,
or of other melanocyte growth factors such as endothelin-3
(EDN3) or hepatocyte growth factor (HGF) cannot rescue the
melanocyte-speciﬁc lack of KIT.
RESULTS AND DISCUSSION
Generation of a conditional Kit allele allowing deletion of the
KIT transmembrane domain
To impair KIT signaling speciﬁcally in melanocytes, we used
the classical Cre/loxP system. We ﬁrst generated a number of
(129/SvJ X C57BL/6)F1 embryonic stem cell (ES) clones
ORIGINAL ARTICLE
1Department of Tissue and Organ Development, Gifu University Graduate
School of Medicine, Gifu, Japan and 2Department of Tumor Pathology,
Regeneration, and Advanced Medical Science, Gifu University Graduate School
of Medicine, Gifu, Japan
Correspondence: Hitomi Aoki, Department of Tissue and Organ
Development, Gifu University Graduate School of Medicine, Gifu 501-1194,
Japan. E-mail: tkunisad@gifu-u.ac.jp
Received 14 January 2015; revised 4 February 2015; accepted 15 February
2015; accepted article preview online 3 March 2015; published online 2 April
2015
Abbreviations: EDN, endothelin 3; EDNRB, endothelin receptor type B;
ES, embryonic stem cell; HGF, hepatocyte growth factor; hk14, human
cytokeratin-14
© 2015 The Society for Investigative Dermatology www.jidonline.org 1829
containing a ﬂoxed Kit allele and an Frt-ﬂanked neomycine
resistance cassette for positive selection. The two loxP sites
were placed to ﬂank exon 10 of Kit, which encodes the
transmembrane domain (Anderson et al., 1990), and the
neomycine resistance cassette was inserted into the adjacent
intron 10. This arrangement was chosen to allow for
conditional deletion of exon 10, whereby direct splicing of
exon 9 to exon 11 would result in premature stop codons in
exon 11. After Cre-recombination, the allele thus resembles
the spontaneous KitW allele in which a mutation in the ﬁrst
nucleotide of intron 10 leads to at least two forms of exon
skipping: a partial exon 10 skipping in mast cells resulting in a
downstream stop codon, and an in-frame three-exon skipping
in bone marrow and brain cells. In either case, translated Kit
molecules from the KitW allele in all the cells expressing Kit
lost transmembrane regions and were incapable of transfering
the signal invoked by the Kitl (Hayashi et al., 1995, Supple-
mentary Figure S1A online). A schematic representation of
the targeting strategy and the molecular analysis of the
initial ES clones are shown in Figure 1a. PCR and Southern
analysis revealed targeting in clones #2 and #3 (Figure 1b–f).
ES clone #3 (of genotype designated Kit2lox/+, as obtained
after removal of the neomycine cassette by transient expres-
sion of FLPe recombinase), was then used to generate
chimeric mice capable of germline transmission of the
targeted allele. Initial inspection of mice heterozygous for
Kit2lox were normally pigmented as were, importantly, mice
homozygous for this allele (Supplementary Figure S2 online),
suggesting that the ﬂoxed Kit allele is functional in vivo. In
experiments described in detail in the Supplementary
Materials online, we further demonstrated that the targeted
allele can indeed be recombined using CRE in ES cells
(Figure 1g). Furthermore, the removal of exon 10 from the
targeted allele in these heterozygous cells was associated with
a reduction of Kit RNA to about half of its wild-type value as
analyzed by RT-PCR and consistent with the likely possibility
of non-sense-mediated decay brought about by the premature
stop codons in exon 11 (Figure 1h–j). Expectedly, surface KIT
protein as analyzed by ﬂow cytometry was also reduced to
about half its normal level (Figure 1l–q; for details see
Supplementary Figure Legends and Supplementary Materials
and Methods online).
Conditional deletion of KIT exon 10 leads to a reduction in
melanoblasts early in the development
We ﬁrst backcrossed the above mentioned clone #3-derived
Kit2lox/+ mice to C57BL/6 mice for at least two generations.
The resulting mice were then crossed with Tyr-Cre mice, in
which a Cre transgene is inserted on the X chromosome and
which express the CRE recombinase protein under the control
of the melanocyte lineage–speciﬁc tyrosinase promoter/
enhancer sequence (Delmas et al., 2003). As Tyr-Cre is
expressed as early as embryonic day (E) 11.5 and Kit is
required early on, we expected to be able to observe the ﬁrst
manifestation of Kit deletion already during embryogenesis.
To this end, we generated Tyr-Cre; Kit2lox/+; DCT-LacZ and
control Tyr-Cre; Kit+/+; DCT-LacZ embryos; in both these
types of embryos, melanoblasts can be followed by way of β-
gal staining (Mackenzie et al., 1997). As previously described,
Dct and Tyr expression do not depend on Kit despite the fact
that they start to be expressed during a Kit-dependent phase of
melanocyte development (Hou et al., 2000; Puig et al., 2009).
As shown in Figure 1, introduction of Cre led to a clear
reduction in LacZ-positive melanoblasts in E13.5–E19.5
embryos (Figure 2a–m), with some embryos showing a total
lack of labeled melanoblasts in both trunk and head regions
(Figure 2e and j). These results indicate that the melanocyte
lineage–restricted deletion of Kit affects melanoblast devel-
opment early during embryogenesis. Furthermore, we per-
formed a ﬂow cytometric analysis of isolated skin cells
obtained from E15.5 Tyr-Cre; Kit2lox/+ embryos that also
carried the RosaR26R-EYFP gene (Srinivas et al., 2001); this
marker gene allows for ﬂuorescent detection of cells in which
CRE-mediated recombination took place. The analysis
revealed that YFP-positive/CD45-negative cells (i.e., cells in
which the Tyr-Cre transgene was active and which include
Figure 1. Generation of Kit-conditional knockout ES cells. (a) Targeting strategy and vector design. A neomycin resistance (Neo) gene under the control of the
PGK promoter, ﬂanked by Frt sequences (PGK–Neo cassette), was combined with a LoxP sequence and inserted into intron 10 for positive selection, and a second
LoxP sequence was inserted into intron 9. The Frt ﬂanked PGK–Neo sequence can be excised by transient Flpe expression. (b and c) Positive targeting events were
identiﬁed by PCR with primers 1 and 2 for the 5′-arm (b) and primers 3 and 4 for the 3′-arm (c). Primers 1 and 4 are located outside the targeting sequence and are
indicated by arrows in (a). Two homologous recombinant ES clones were obtained. (d and e) Southern analysis of targeting events. (d) PCR products in “D” were
probed with the 3′-arm probe. (e) Genomic DNA from ES cells, digested with SpeI, was probed with a Neo probe. (f) Primers 5 and 6 were used to identify the
expected product size after successful Cre-mediated recombination in ES cells with the genotype Kit2lox/+. The size difference represents the inserted single loxP
site plus ﬂanking sequences. (g–q) Kit expression in doxycycline-inducible Kit-conditional knockout ES cells. (g) Genotyping results from the conditional Kit
knockout ES cell lines. The conditional Kit knockout ES cell lines containing both the Rosa 26-M2rtTA allele and the ColA1-tetOP-Cre allele were treated with or
without doxycycline to induce Cre recombinase, and then DNAs were extracted to serve as templates for PCR analysis. Primers 5 and 7 were used for 2loxP,
1loxP, and wild-type genotyping. Clones A and B are Ktt2lox/+; Rosa 26-M2rtTA; ColA1-tetOP-Cre ES cells and clone C represents Kit+/+; Rosa 26-M2rtTA;
ColA1-tetOP-Cre ES cells used as control. The generation of the Kit1lox/+ allele was clearly indicated in clones A and B. (h–j) Real-time RT-PCR analysis of relative
Kit mRNA levels (normalized to the β-actin mRNA level). RNA samples were extracted from the conditional Kit knockout ES cell lines containing both the Rosa
26-M2rtTA allele and ColA1-tetOP-Cre allele treated with or without doxycycline. Three independent primer pairs allowed ampliﬁcation of exon 2 (h), exon 10
(i), and exon 11 (j). Bars represent means± SE (n=3 for each group). ES cells 3 days after doxycycline treatment were used. (k–q) Flow cytometric analysis of KIT
protein in the conditional Kit knockout ES cell lines. The same samples used in h-j were stained with antibodies against Kit (2B8). The results from Kit expression of
each cell source are shown in l-q, and their mean and median intensities are also indicated in k. FACS analysis revealed a decrease in Kit-APC expression in the
conditional Kit knockout ES cell lines 3 days after doxycycline treatment. APC, allophycocyanin; ES, embryonic stem cell; RT-PCR, reverse transcriptase–PCR.
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early melanocyte progenitors (Delmas et al., 2003) but
exclude hematopoietic cells) expressed KIT at lower levels
at the cell surface than corresponding cells from embryos
harboring a wild-type Kit allele (Figure 2n–q). Taken together,
the results suggest that CRE-mediated reduction of KIT in
melanoblasts affects their early development.
Lineage-speciﬁc deletion of Kit exon 10 leads to an extensive
spotting phenotype in vivo
The reduction in melanoblasts during embryogenesis sug-
gested that Tyr-Cre; Kit2lox/+ mice would show a white
spotting phenotype already early after birth. As shown in
Figure 3a–h, this was indeed the case. In contrast to control
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Figure 2. Melanoblast-restricted Kit ablation leads to embryonic impairment of melanoblast development. (a–e) Embryos of the indicated ages and
genotypes, each carrying the DCT-LacZ transgene, were labeled for β-gal expression and photographed using a dissection scope. c–e represents views of
dorsal skin. (f–m) β-gal staining of trunk or head skin of E19.5 embryos of the indicated genotypes. Scale bars = 500 μm. (n–q) Flow-cytometric analysis
of KIT protein expression in melanoblasts from the skin of E15.5 embryos of the indicated genotypes. Cells were sorted for YFP and CD45 and then labeled
with anti-KIT monoclonal antibody 2B8. FACS analysis revealed a decrease in KIT-APC expression in cells of Tyr-Cre; Kit2lox/+; Rosa-R26R-EYFP embryos
(o and q). APC, allophycocyanin; E15.5, embryonic day 15.5.
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Tyr-Cre; Kit+/+ mice, Tyr-Cre; Kit2lox/+ mice showed wide-
spread spotting, both ventrally and dorsally, already at
postnatal day (P) 9, and the spots remained ﬁxed later in life
(shown up to P50 in Figure 3). The numbers of mice analyzed
for these studies are shown in Supplementary Table S1 and S2
online. It should be noted that neither in these nor in
subsequent experiments did we observe a systematic differ-
ence in white spotting between males and females even
though random inactivation of the X chromosome, on which
Tyr-Cre lies, was expected to lower the number of cells
available for Cre-mediated recombination in females by half
(see also Supplementary Table S2 online). Direct analysis of
skin sections for pigmentation in anagen and telogen hair
follicles as well as corresponding speciﬁc labeling of melano-
cytes using the above mentioned Dct-LacZ transgene showed
the expected absence of melanocytes in hair follicles in areas
of the white spots (Figure 3i–af, Supplementary Table S3
online). These results clearly indicate that the melanocyte
lineage restricted reduction of Kit signaling, which is precisely
controlled by the melanocyte-speciﬁc induction of the Kit loss-
of-function mutation, is sufﬁcient to induce the white spotting
phenotype caused by the complete lack of melanocyte lineage
cells. We did not, however, speciﬁcally address the question of
whether pigmented cells in the dark areas of the coat have, or
have not, escaped CRE-mediated recombination, chieﬂy
because the extensive pigmentation remaining in germline
KitW/+ mice, which are heterozygous for a null allele, suggests
that gene dose reductions in Kit are compatible with the
development of pigmented melanocytes.
Ectopic Kitl expression has no effect on the phenotype
associated with melanocyte-speciﬁc reduction of KIT
As mentioned above, exon 10 elimination in melanocytes of
Tyr-Cre; Kit2lox/+ mice resembles (although is not identical to)
that found in mice carrying the KitW allele. KitW/+ mice
usually show white spotting only on the ventral side, but the
spots rarely extend to the dorsum (Figure 2 of Russell and
McFarland, 1966 and also Figure 2 of Geissler et al., 1981).
Even when backcrossed to C57BL/6 in similar ways as Tyr-
Cre; Kit2lox/+ mice, white spotting in KitW/+ mice was still
restricted to the ventral side (data not shown). In contrast, Tyr-
Cre; Kit2lox/+mice usually have irregular white dorsal spots as
shown in Figure 3. Occasionally, the entire dorsal coat can be
white except for a smaller black spot (for instance in
Figure 4m, right mouse). This phenotype resembles that seen
with particularly severe point mutations in the Kit coding
region, such as in KitW37/+ or KitW42/+ mice (Figure 1 of
Geissler et al., 1981).
It has been observed previously that KitWsh/KitWsh mutants,
which carry a genomic inversion that disrupts the 5′
regulatory region of Kit, ectopically express KIT protein in
the embryonic mesenchyme. It has been suggested that this
ectopic expression sequesters secreted KITL to cause a white
spotting phenotype (Duttlinger et al., 1993). Similarly, ectopic
Kit expression in somites and lateral mesenchyme of embryos
carrying the Patch mutation (characterized by a genomic
deletion that includes the gene for platelet-derived growth
factor receptor A) causes a reduction in the number of
migrating melanoblasts leading to white spotting (Wehrle-
Haller et al., 1996). It was, therefore, conceivable that, in
Tyr-Cre; Kit2lox/+ mice, the normal expression of KIT protein
in cells other than melanocytes may likewise sequester KITL
available for developing melanocytes, unlike in Kit mutants in
which Kit expression is normally reduced in all Kit-expressing
cells. In addition, potentially secreted forms of KIT protein,
however unlikely in our mice where Kit expression from
the targeted allele is signiﬁcantly reduced, might help
sequester KITL.
If KITLs were indeed sequestered, then KITL overexpression
should overcome this sequestration. Hence, we crossed
Tyr-Cre; Kit2lox/+ mice with mice containing transgenic
Kitl cDNAs under the control of the human cytokeratin-14
(hk14) promoter, allowing for the expression of KITL in
the basal layer of the epidermis (Kunisada et al., 1998b;
Aoki et al., 2009). The resulting Tyr-Cre; Kit2lox/+; hk14-Kitl
mice, however, showed a similar coat pigmentation pattern
as Tyr-Cre; Kit2lox/+ mice (Figure 4a–n, Supplementary
Table S1–S3 online). In the pigmented areas, the density of
pigmented melanocytes in anagen hair follicles and epider-
mal skin of Tyr-Cre; Kit2lox/+;hk14-Kitl mice (Figure 4p and s;
Supplementary Table S4 online) was also similar to that seen
in Tyr-Cre; Kit+/+; hk14-Kitl mice (Figure 4o and r). No
pigmented melanocytes were observed in the skin covered
with white hairs except for pigmentation in sebaceous glands
(Figure 4q and t, arrows point to sebaceous glands).
Furthermore, after introduction of the Dct-LacZ transgene,
there was also no increase in LacZ-positive melanocytes in
Tyr-Cre; Kit2lox/+; hk14-Kitl mice, and white skin in these
mice showed few if any LacZ-positive melanoblasts at the
anagen phase (Figure 4w and z,Supplementary Table S5
online). In addition, at the telogen stage, we observed
pigmented melanocytes and LacZ-positive melanocyte stem/
precursor cells only in the pigmented skin regions (Figure
4aa–al). These results suggest that sequestration of exogenous
KITL is unlikely to account for the white spotting phenotype of
the Tyr-Cre; Kit2lox/+ mice. Thus, the molecular or cellular
mechanisms underlying larger white spots of Tyr-Cre; Kit2lox/+
mice compared with those of KitW/+ mice were still not
addressed. Nevertheless, it is important to note that despite
the previously observed increases in the number of mast cells
in the dermal skin of hk14-Kitl mice (Kunisada et al., 1998a),
the increased availability of KITL in such mice is restricted to
the vicinity of basal epidermal cells and may thus not affect
early migrating melanoblasts.
The effect of in vivo ectopic EDN3 and HGF expression on the
melanocyte-speciﬁc Kit exon 10 deletion
It is well established that melanocyte development not only
depends on KIT signaling but is also inﬂuenced by the action
of a number of other growth factors including EDN3 and
HGF. For instance, in mice, deﬁciency in the receptor for
EDN3, EDN receptor B (EDNRB), results in the absence of
coat melanocytes. In vitro, however, EDNRB-deﬁcient mela-
noblasts can be rescued by exogenous KITL, suggesting that
EDNRB, which, like KIT, is also expressed in multiple cell
types, can act in a cell non-autonomous way by inﬂuencing
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KITL-expressing cells. Although KITL rescue initiates devel-
opment of EDNRB-negative melanocyte development to the
tyrosinase-positive stage, however, pigmentation still seems to
depend on cell-autonomous EDNRB signaling (Hou et al,
2004). Following the logic provided by this example, we
tested, therefore, whether melanocyte development in
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Tyr-Cre; Kit2lox/+ mice could be rescued, even if only
partially, with additional growth factors. To this end, we
crossed Tyr-Cre; Kit2lox/+ mice with hk14-Edn3 (Yamazaki
et al., 2005) or hk14-HGF (Kunisada et al., 2000) mice in
which the respective factors are expressed under the control
of the above mentioned hk14 promoter. The resulting mice,
however, showed a spotting phenotype comparable to that
seen in the absence of these growth factor transgenes
(Figure 5, Supplementary Table S1–S3 online). In these mice,
pigmented melanocytes were detected in the macroscopically
pigmented dermal skin and also a signiﬁcant reduction or
almost complete depletion of LacZ-positive melanoblasts was
observed in the non-pigmented areas of their skin
(Supplementary Figure S3 online for hk14-Edn3 mice and
Supplementary Figure S4 online for hk14-HGF mice). These
results suggest that these growth factors, at least when
expressed at the time points and locations afforded by the
respective transgenes, cannot rescue the development of
melanocytes whose KIT expression is impaired and under-
score the cell-autonomous importance of this signaling
pathway for normal coat pigmentation in mice.
Recently, Kitl was reported to transduce Kit signal mainly
through the PI3K pathway instead of the Raf/Erk pathway in
normal melanocytes (Monsel et al., 2010). The PI3K pathway
was suggested to have a role for the early melanocyte
development in wild-type embryos instead of the Raf/Erk
pathway (Valluet et al., 2012). Hence, melanocyte cell–
antonomous Kit signaling responsible for the coat phenotype
may act through the PI3K pathway, and thus changes to a
more Raf/Erk-dependent state may lead to the pigmental
disorders or melanomas in Kit-mutated melanocytes.
It has been reported previously that signaling through cell
surface receptors may effect melanocyte development by
acting directly in melanocytes as well as indirectly by acting
through other cell types. Here we ﬁnd that impairment of Kit
in melanocytes is sufﬁcient to generate a severe white spotting
phenotype in mice, suggesting that lack of Kit in other Kit-
expressing cell types may be of limited importance for
melanocytes. Hence, attempts to rescue melanocytes in Kit
mutants would have to focus on restoring KIT signaling in
melanocytes themselves rather than in neighboring cells.
MATERIALS AND METHODS
Animals
The following transgenic mice were maintained in our animal
facility: hk14-Edn3 (Yamazaki et al., 2005); hk14-Kitl (Kunisada et al.,
1998b); hk14-HGF (Kunisada et al., 2000); and DCT-LacZ transgenic
mice (Mackenzie et al., 1997). Kit2lox/+ mice were generated from
Kit2lox/+ ES cell lines, for which details of construction of the Kit-
conditional knockout vector and generation of ES cells and mice as
well as ES cell culture conditions and derivation of the conditional Kit
knockout ES cell line were described in Supplementary Materials and
Methods online. Rosa 26-M2rtTA; ColA1-tetOP-Cre mice (Yamada
et al., 2010; Aoki et al., 2012), RosaR26R-EYFP mice (Srinivas et al.,
2001), were kindly provided by Dr. Frank Costantini, and Tyr-CreA
(here called Tyr-Cre) mice (Delmas et al., 2003) were bred with
Kit2lox/+ mice to generate compound transgenic mice. For Cre
induction in ColA1-tetOP-Cre mice, doxycycline (2 mgml− 1) was
administered in the drinking water and supplemented with
10mgml− 1 sucrose (Hochedlinger et al., 2005). Mice were housed
in standard animal rooms with food and water ad libitum under
controlled humidity (50± 10%) and temperature (22± 2 °C)
conditions. Illumination was from 0800 to 2000 hours. For embryo
timing, vaginal plugs were checked and the day a plug was detected
was considered E0.5. All animal experiments were approved by the
Animal Research Committee of the Graduate School of Medicine,
Gifu University.
Flow cytometric analysis
Methods for cell preparation and ﬂow cytometric analysis were
performed as reported in detail previously (Aoki et al., 2009). Brieﬂy,
E15.5 embryos were collected, and their back skins were
quickly dissected on ice into very small pieces. These small pieces
of skin were treated for 30 minutes at 37 °C with 0.25% typsin per
1 mM EDTA (Invitrogen, Carlsbad, CA), 0.1% collagenase 1 (Sigma-
Aldrich, St Louis, MO), and 1X dispase (Roche, Basel, Switzerland).
The cells of these small pieces were dissociated by gentle pipetting,
and the cell suspensions strained through 100-mesh nylon (Sansho,
Japan).
Cell suspensions were centrifuged and resuspended in a staining
medium ( phosphate-buffered saline containing 3% fetal calf serum).
The dissociated cells were then blocked with rat anti-mouse Fc
gamma receptor (2.4-G2, BD Biosciences, San Jose, CA) on ice for
30–40minutes. After another wash with staining medium, the cells
were stained with phycoerythrin (PE)-conjugated rat anti-mouse
CD45 (30-F11, BD Bioscience) on ice for 30–40 minutes, washed,
and incubated with allophycocyanin-conjugated rat anti-mouse
c-KIT (2B8, BD Bioscience) on ice for 30–40 minutes. The cells
were washed and resuspended in staining medium containing 3
mgml−1 propidium iodide (Calbiochem, San Diego, CA) to exclude
the dead cells.
All cell analyses were performed with a FACS Aria dual-laser ﬂow
cytometer (BD Bioscience). propidium iodide–negative cells were
analyzed for CD45-PE and Tyr-Cre; RosaR26R-EYFP. YFP-positive/
CD45-negative cells were selected and analyzed for Kit-
allophycocyanin expression.
Figure 3. Spotting phenotype after melanocyte-restricted deletion of Kit. (a–h) Dorsal (a–d) and ventral (e–h) views of mice of the indicated genotypes and postnatal
ages. Note extensive white spotting in Tyr-Cre; Kit2lox/+ mice. (i–af) Sections of the skin of adult mice of the indicated genotypes analyzed for the presence of
pigmented melanocytes and LacZ-positive cells as indicated. For Tyr-Cre; Kit2lox/+ skin, pigmented and unpigmented areas were analyzed separately, and for
both the Kit+/+ and the Kit2lox/+ genotypes skins at both anagen and telogen stages of the hair cycle were analyzed. Note that at the anagen stage, in unpigmented
areas of Tyr-Cre; Kit2lox/+ skin, there are no pigmented hairs (k) nor pigment granules (n). Furthermore, the unpigmented areas of Tyr-Cre; Kit2lox/+; DCT-LacZ
mice also show the absence of LacZ-positive cells in hair follicles (q and t). Similar observations were made at the telogen stage (w, c, ac, af). Arrowheads in aa,
ab, ad, and ae point to LacZ-positive cells in follicular bulge regions. Scale bars = 500 μm in i, o, u, aa; 100 μm in l, r, x, ad. HE, hematoxylin and eosin.
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Histology
Skin specimens were collected from euthanized mice and were ﬁxed
by immersion overnight in 10% formalin in phosphate buffer (pH
7.2). Specimens were dehydrated with ethanol, soaked in xylene,
and then embedded in parafﬁn. Horizontal serial sections were
prepared at 3-mm thickness using a Leica RM2125RT microtome
(Leica RM2125RT, Leica Microsystems Inc., Bannockburn, IL) and
then were stained with hematoxylin and eosin. LacZ staining was
performed as reported in detail previously (Aoki et al., 2011) and also
described in Supplementary Materials and Methods online.
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